Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Lucid Diagnostics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q3 2022
- Shares held
- 1.92M
- −388.3K (−16.9%) vs. Q3 2022
- Total value
- $2.60M
- −$919.0K (−26.1%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 4
- 9 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUCD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 115 | $65.7M |
| Q1 2026 | 103 | $41.0M |
| Q4 2025 | 89 | $35.0M |
| Q3 2025 | 86 | $35.5M |
| Q2 2025 | 72 | $21.7M |
| Q1 2025 | 49 | $14.0M |
| Q4 2024 | 33 | $2.70M |
| Q3 2024 | 29 | $2.00M |
| Q2 2024 | 34 | $1.64M |
| Q1 2024 | 30 | $1.69M |
| Q4 2023 | 25 | $2.46M |
| Q3 2023 | 24 | $2.24M |
| Q2 2023 | 18 | $2.59M |
| Q1 2023 | 19 | $2.49M |
| Q4 2022 | 23 | $2.60M |
| Q3 2022 | 23 | $3.52M |
| Q2 2022 | 31 | $5.55M |
| Q1 2022 | 32 | $9.09M |
| Q4 2021 | 35 | $17.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Lucid Diagnostics Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18 | $24 | 0.00% | +18 | New |
| Wells Fargo & Company | 58 | $79 | 0.00% | +2+3.6% | Added |
| Advisor Group Holdings, Inc. | 1,000 | $1.00K | 0.00% | +678+210.6% | Added |
| Morgan Stanley | 893 | $1.21K | 0.00% | −18,361−95.4% | Reduced |
| Belpointe Asset Management LLC | 1,500 | $2.04K | 0.00% | +1,500 | New |
| Tower Research Capital LLC (TRC) | 2,561 | $3.00K | 0.00% | −4,721−64.8% | Reduced |
| CWM, LLC | 1,920 | $3.00K | 0.00% | −100−5.0% | Reduced |
| Arcus Capital Partners, LLC | 3,100 | $4.22K | 0.00% | +3,100 | New |
| UBS Group AG | 3,565 | $4.85K | 0.00% | −1,396−28.1% | Reduced |
| State Street Corp | 10,521 | $14.3K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 14,400 | $19.6K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 17,814 | $24.0K | 0.00% | −6,602−27.0% | Reduced |
| BlackRock Inc. | 18,238 | $24.8K | 0.00% | +412+2.3% | Added |
| Geneos Wealth Management Inc. | 33,850 | $46.0K | 0.00% | −7,000−17.1% | Reduced |
| Verition Fund Management LLC | 36,166 | $49.2K | 0.00% | 00.0% | Unchanged |
| Levin Capital Strategies, L.P. | 36,799 | $50.0K | 0.01% | +36,799 | New |
| Geode Capital Management, LLC | 41,543 | $56.0K | 0.00% | +2,427+6.2% | Added |
| Kornitzer Capital Management Inc | 133,000 | $180.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 135,000 | $183.6K | 0.00% | −50,000−27.0% | Reduced |
| Nantahala Capital Management, LLC | 279,537 | $380.2K | 0.03% | −6,895−2.4% | Reduced |
| Vanguard Group Inc | 319,433 | $434.4K | 0.00% | +670.0% | Added |
| Luminus Management LLC | 825,000 | $1.12M | 0.28% | −21,662−2.6% | Reduced |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −264,653−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −35,333−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,602−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −973−100.0% | Sold out |